Page last updated: 2024-09-02

quinaprilat and ng-nitroarginine methyl ester

quinaprilat has been researched along with ng-nitroarginine methyl ester in 1 studies

Compound Research Comparison

Studies
(quinaprilat)
Trials
(quinaprilat)
Recent Studies (post-2010)
(quinaprilat)
Studies
(ng-nitroarginine methyl ester)
Trials
(ng-nitroarginine methyl ester)
Recent Studies (post-2010) (ng-nitroarginine methyl ester)
9223412,6401172,342

Protein Interaction Comparison

ProteinTaxonomyquinaprilat (IC50)ng-nitroarginine methyl ester (IC50)
Neutrophil elastaseHomo sapiens (human)2.7
Nitric oxide synthase, endothelialHomo sapiens (human)2.1
Nitric oxide synthase, brainHomo sapiens (human)1.1167
Nitric oxide synthase, inducibleMus musculus (house mouse)2.6
Nitric oxide synthase, inducibleHomo sapiens (human)8
Collagenase 3Homo sapiens (human)2.7

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, M; Chen, X; Fujiwara, H; Lu, C; Minatoguchi, S; Misao, Y; Takemura, G; Uno, Y; Wang, N1

Other Studies

1 other study(ies) available for quinaprilat and ng-nitroarginine methyl ester

ArticleYear
Quinaprilat reduces myocardial infarct size involving nitric oxide production and mitochondrial KATP channel in rabbits.
    Journal of cardiovascular pharmacology, 2003, Volume: 41, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Decanoic Acids; Heart Ventricles; Hemodynamics; Hydroxy Acids; Hydroxyl Radical; Male; Membrane Proteins; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Channel Blockers; Potassium Channels; Rabbits; Tetrahydroisoquinolines

2003